IL1B and coronary artery disorder: A trial of 15 men with stable CAD demonstrated that six weeks of supplementation with twenty billion CFUs of Lactobacillus plantarum induced favorable metabolic effects including downregulation of inflammation driven by IL-1β, TNF-a, and upregulation of regulatory T-cells (3).